Comparison of tissue genotyping (TG) vs circulating tumor DNA (ctDNA) for selection of matched therapy and impact on clinical outcomes among patients with metastatic breast cancer (MBC).

1020Background: Oncogenic mutations are attractive targets for targeted therapies, but the clinical impact is unclear. We evaluated the impact of TG or ctDNA on the selection of matched therapy and...